AbbVie Inc (ABBV) insider trading
Every open-market stock purchase and sale by AbbVie Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Healthcare.
Insider activity at a glance
- Nicholas Donoghoe (VP) sold $8.2M in the last 90 days.
- Last insider buy: Brian L Durkin (VP), $51.8K, 6 years ago.
- Congress: Josh Gottheimer sold $1K to $15K, 5 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $18.9M (4 sales). Last close $261.83 on Aug 20, 2026.
Recent ABBV insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 14, 2026 | Nicholas Donoghoe (VP) | Sold | $8.2M |
| Aug 14, 2026 | Nicholas Donoghoe (VP) | Bought (not open market) | — |
| May 8, 2026 | Thomas C Freyman (Insider) | Bought (not open market) | — |
| May 8, 2026 | Frederick H Waddell (Insider) | Bought (not open market) | — |
| May 8, 2026 | Brett J Hart (Insider) | Bought (not open market) | — |
| May 8, 2026 | Rebecca B Roberts (Insider) | Bought (not open market) | — |
| May 8, 2026 | Melody B Meyer (Insider) | Bought (not open market) | — |
| May 8, 2026 | William H.l. Burnside (Insider) | Bought (not open market) | — |
| May 8, 2026 | Thomas J Falk (Insider) | Bought (not open market) | — |
| May 8, 2026 | Edward J Rapp (Insider) | Bought (not open market) | — |
| May 8, 2026 | Jennifer L. Davis (Insider) | Bought (not open market) | — |
| May 8, 2026 | Susan E Quaggin (Insider) | Bought (not open market) | — |
| May 8, 2026 | Roxanne S Austin (Insider) | Bought (not open market) | — |
| May 5, 2026 | Josh Gottheimer (Congress) | Sold | $1K–$15K |
| Mar 31, 2026 | Edward J Rapp (Insider) | Bought (not open market) | $33.7K |
| Mar 31, 2026 | Susan E Quaggin (Insider) | Bought (not open market) | $15.4K |
| Mar 31, 2026 | Robert J Alpern (Insider) | Bought (not open market) | $7.6K |
| Mar 4, 2026 | David Ryan Purdue (VP) | Sold | $1.2M |
| Mar 2, 2026 | Perry C Siatis (VP) | Sold | $2.4M |
| Mar 2, 2026 | Perry C Siatis (VP) | Sold | $1.3M |
| Mar 2, 2026 | Perry C Siatis (VP) | Sold | $612K |
| Feb 27, 2026 | Robert A. Michael (CEO) | Sold (not open market) | $8.5M |
| Feb 27, 2026 | Jeffrey Ryan Stewart (C-suite exec) | Sold (not open market) | $5.5M |
| Feb 27, 2026 | Scott T Reents (CFO) | Sold (not open market) | $5M |
| Feb 27, 2026 | Azita Saleki-Gerhardt (C-suite exec) | Sold (not open market) | $3.8M |
Who's trading ABBV
- Nicholas Donoghoe, VP: sold $8.2M (1 sale), last Aug 14, 2026
- William H.l. Burnside, Insider: other filings, last May 8, 2026
- Frederick H Waddell, Insider: other filings, last May 8, 2026
- Roxanne S Austin, Insider: other filings, last May 8, 2026
- Jennifer L. Davis, Insider: other filings, last May 8, 2026
- Melody B Meyer, Insider: other filings, last May 8, 2026
- Edward J Rapp, Insider: other filings, last May 8, 2026
- Susan E Quaggin, Insider: other filings, last May 8, 2026
- Brett J Hart, Insider: other filings, last May 8, 2026
- Rebecca B Roberts, Insider: other filings, last May 8, 2026
- Thomas J Falk, Insider: other filings, last May 8, 2026
- Thomas C Freyman, Insider: other filings, last May 8, 2026
- Josh Gottheimer, Congress: sold $8K (1 sale), last May 5, 2026
- Robert J Alpern, Insider: other filings, last Mar 31, 2026
- David Ryan Purdue, VP: sold $1.2M (1 sale), last Mar 4, 2026
Get free alerts when an insider at AbbVie Inc files a new trade →